STAT

Why a growing number of women with breast cancer are choosing double mastectomy

Even as cancer treatments have become increasingly targeted, a growing number of women with cancer in one breast are opting for a double mastectomy.

Three years ago, Crystal Collum was 37 years old with three kids at home, “kind of just trucking through life” in Columbia, S.C., when she felt a lump on her breast while showering. She didn’t hesitate — she’d watched her best friend go through breast cancer years earlier, and she knew what to do. Within three weeks she was starting chemotherapy.

But soon after, she was confronted with a choice that even she was unprepared for: have a lumpectomy, a targeted surgery that removes only the tumor, or have a double mastectomy — surgery to completely remove both breasts. The decision was an agonizing one.

“I really could not think about anything else. I really couldn’t. It consumed me,” Collum recalled. “There’s so many things during this process that you have no control over, and then the biggest decision of the entire thing is kind of dropped in your lap and you’re like, no, I don’t feel like I should be making this decision.”

After weeks of soul-searching, information-gathering, talking to

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks